Tpex cells: the game-changer in targeted tumor immunotherapy
Progenitor exhausted CD8+ T (Tpex) cells have emerged as a pivotal component in tumor immunotherapy due to their unique ability...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
Progenitor exhausted CD8+ T (Tpex) cells have emerged as a pivotal component in tumor immunotherapy due to their unique ability...
“These findings indicate that renalase-1 is a potential antigen for TCR recognition in melanoma and could be considered as a...
SAN ANTONIO, Aug. 8, 2024 – A drug effective in treating breast cancer shows new promise in addressing breast cancer...
LOS ANGELES — A study from the USC Head and Neck Center, part of Keck Medicine of USC and the USC...
About The Study: This cohort study highlights an association between cannabis-related disorder and the development of head and neck cancer in...
A research team led by Professor Ying Wai CHAN from the School of Biological Sciences at The University of Hong...
For decades, researchers have worked to develop therapies that can prime the immune system to recognize and attack proteins on...
An activity pattern in certain genes responsible for building proteins known as spleen tyrosine kinases can predict which melanoma patients...
CAMBRIDGE, Mass., Aug 8, 2024 --- Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced ISM6331,...
Using zebrafish “Avatars”, an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine